Delius Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2014.
2014 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Delius Pharmaceuticals Private Limited

Delius Pharmaceuticals Private Limited, a active private limited company, was established on 14 August 2014 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232DL2014PTC270434. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹9.90 M and a paid-up capital of ₹6.50 M.

It upholds a compliant status. Its leadership includes Digvijay Kumar Shrivastawa (Director), Kunal Kumar (Director). Past directors included Sapna Srivastwa, Ved Prakash. It holds ₹2.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 October 2025, with the balance sheet filed on 31 March 2025. It is based at Unit No. 370, Commercial Building Vegas Mall, Dwarka Sector-14, New Delhi, Delhi, 110078.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2014PTC270434

  • Registration Number

    270434

  • Incorporation Date

    14 August 2014

  • Authorized Capital

    ₹9.90 M

  • Paid-Up Capital

    ₹6.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 9.90 M
  • Paid Up Capital ₹ 6.50 M
  • Company Age 11 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.00 Cr
  • Revenue Growth **** 877.14%
  • Profit Growth **** 749.53%
  • Ebitda **** -3244.52%
  • Net Worth 468.09%
  • Total Assets **** 361.57%
Company report

Delius Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Delius Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Delius Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Digvijay Kumar Shrivastawa Director 14 Aug 2014 Current
Kunal Kumar Director 31 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Director 24 Apr 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Delius Pharmaceuticals.

Delius Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 877.14% increase. The company also saw a substantial improvement in profitability, with a 749.53% increase in profit. The company's net worth Soared by an impressive increase of 468.09%.

Delius Pharmaceuticals revenue growth over time
Delius Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 877.14%
*******
*******
*******
*******
Revenue from Operations
*******
 876.33%
*******
*******
*******
*******
Total Assets
*******
 361.57%
*******
*******
*******
*******
Profit or Loss
*******
 749.53%
*******
*******
*******
*******
Net Worth
*******
 468.09%
*******
*******
*******
*******
EBITDA
*******
 -3244.52%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Delius Pharmaceuticals?

Unlock access to Delius Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹20,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 2.00 Cr
Latest Charge Details
Date Lender Amount Status
14 Jan 2025 Others ₹2.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Delius Pharmaceuticals?

Delius Pharmaceuticals has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Delius Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delius Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Delius Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Delius Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Oct 2025 as per latest MCA records. was documented.

  • Director Appointment

    The activity Kunal Kumar was appointed as a Director was appointed as a Director on 31 Jul 2025 & has been associated with this company since 9 months 20 days . was completed.

  • Balance Sheet

    Delius Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 20.00 M with Charge ID 101050962 was registered on 14 Jan 2025. was recorded as a recent event.

  • Director Appointment

    Progress on Digvijay Kumar Shrivastawa was appointed as a Director was appointed as a Director on 14 Aug 2014 & has been associated with this company since 11 years 9 months . was documented.

  • Company Incorporation

    Progress on Delius Pharmaceuticals Private Limited was registered on 14 Aug 2014 with Roc Delhi & aged 11 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Delius Pharmaceuticals Private Limited?

The CIN of Delius Pharmaceuticals Private Limited is U24232DL2014PTC270434.

Where is Delius Pharmaceuticals Private Limited headquartered?

Delius Pharmaceuticals Private Limited is headquartered at Unit No. 370, Commercial Building Vegas Mall, Dwarka Sector-14, New Delhi, Delhi, 110078.

When was Delius Pharmaceuticals Private Limited incorporated?

Delius Pharmaceuticals Private Limited was incorporated on 14 August 2014.

Who are the current directors of Delius Pharmaceuticals Private Limited?

The current directors of Delius Pharmaceuticals Private Limited are

What is the primary industry of Delius Pharmaceuticals Private Limited?

The primary industry of Delius Pharmaceuticals Private Limited is Trade.

Is Delius Pharmaceuticals Private Limited a listed company?

Delius Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Delius Pharmaceuticals Private Limited?

The authorized capital of Delius Pharmaceuticals Private Limited is ₹9.90 M, and the paid-up capital is ₹6.50 M.

What is the compliance status of Delius Pharmaceuticals Private Limited?

The compliance status of Delius Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available